↓ Skip to main content

Dove Medical Press

Gender differences in the adverse events’ profile registered in seven observational studies of a wide gender-medicine (MetaGeM) project: the MetaGeM safety analysis

Overview of attention for article published in Drug Design, Development and Therapy, September 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

blogs
1 blog
twitter
1 X user

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
41 Mendeley
Title
Gender differences in the adverse events’ profile registered in seven observational studies of a wide gender-medicine (MetaGeM) project: the MetaGeM safety analysis
Published in
Drug Design, Development and Therapy, September 2016
DOI 10.2147/dddt.s97088
Pubmed ID
Authors

Delia Colombo, Emanuela Zagni, Mihaela Nica, Sara Rizzoli, Alessandra Ori, Gilberto Bellia

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Uruguay 1 2%
Unknown 40 98%

Demographic breakdown

Readers by professional status Count As %
Other 6 15%
Student > Bachelor 6 15%
Student > Ph. D. Student 4 10%
Researcher 4 10%
Student > Postgraduate 4 10%
Other 10 24%
Unknown 7 17%
Readers by discipline Count As %
Medicine and Dentistry 13 32%
Pharmacology, Toxicology and Pharmaceutical Science 5 12%
Social Sciences 3 7%
Nursing and Health Professions 2 5%
Biochemistry, Genetics and Molecular Biology 2 5%
Other 5 12%
Unknown 11 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 June 2023.
All research outputs
#4,312,648
of 25,374,647 outputs
Outputs from Drug Design, Development and Therapy
#269
of 2,268 outputs
Outputs of similar age
#68,244
of 348,376 outputs
Outputs of similar age from Drug Design, Development and Therapy
#7
of 71 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 348,376 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 71 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.